Literature DB >> 35244687

Similar effectiveness of the inactivated vaccine BBIBP-CorV (Sinopharm) and the mRNA vaccine BNT162b2 (Pfizer-BioNTech) against COVID-19 related hospitalizations during the Delta outbreak in the UAE.

Mira Mousa1,2, Mohammed Albreiki1, Fatima Alshehhi3, Safiya AlShamsi4, Nada Al Marzouqi3, Tayba Alawadi3, Hussain Alrand3, Habiba Alsafar1,5,6,7, Asma Fikri3,8.   

Abstract

Entities:  

Keywords:  B.1.617.2; BBIBP-CorV; BNT162b2; COVID-19; Delta; SARS-CoV-2; vaccine effectiveness

Mesh：

Substances：

Year:  2022        PMID： 35244687      PMCID： PMC8903474          DOI： 10.1093/jtm/taac036

Source DB:  PubMed          Journal:  J Travel Med        ISSN： 1195-1982            Impact factor:   39.194


× No keyword cloud information.
  7 in total

Review 1.  Analysis of the Protective Efficacy of Approved COVID-19 Vaccines Against Various Mutants.

Authors:  Chaonan Li; Yikai Guo; Zhongbiao Fang; Haiyan Zhang; Yanjun Zhang; Keda Chen
Journal:  Front Immunol       Date:  2022-04-28       Impact factor: 8.786

Review 2.  An overview on inactivated and live-attenuated SARS-CoV-2 vaccines.

Authors:  Saeed Khoshnood; Maniya Arshadi; Sousan Akrami; Maryam Koupaei; Hossein Ghahramanpour; Aref Shariati; Nourkhoda Sadeghifard; Mohsen Heidary
Journal:  J Clin Lab Anal       Date:  2022-04-14       Impact factor: 3.124

3.  Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study).

Authors:  Zoltán Vokó; Zoltán Kiss; György Surján; Orsolya Surján; Zsófia Barcza; István Wittmann; Gergő Attila Molnár; Dávid Nagy; Veronika Müller; Krisztina Bogos; Péter Nagy; István Kenessey; András Wéber; Lőrinc Polivka; Mihály Pálosi; János Szlávik; György Rokszin; Cecília Müller; Zoltán Szekanecz; Miklós Kásler
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

4.  Effectiveness and Cost-Effectiveness of Inactivated Vaccine to Address COVID-19 Pandemic in China: Evidence From Randomized Control Trials and Real-World Studies.

Authors:  Yaqun Fu; Jingyu Zhao; Xia Wei; Peien Han; Li Yang; Tao Ren; Siyan Zhan; Liming Li
Journal:  Front Public Health       Date:  2022-07-19

5.  Evaluation of the role of vaccination in the COVID-19 pandemic based on the data from the 50 U.S. States.

Authors:  Rongfang Nie; Zeinab Abdelrahman; Zhixian Liu; Xiaosheng Wang
Journal:  Comput Struct Biotechnol J       Date:  2022-08-08       Impact factor: 6.155

Review 6.  The Role of Cellular Immunity in the Protective Efficacy of the SARS-CoV-2 Vaccines.

Authors:  Zhongjie Sun; Tingxin Wu; Huangfan Xie; Yuhuan Li; Jinlan Zhang; Xuncheng Su; Hailong Qi
Journal:  Vaccines (Basel)       Date:  2022-07-09

7.  Vaccination with the Inactivated Vaccine (Sinopharm BBIBP-CorV) Ensures Protection against SARS-CoV-2 Related Disease.

Authors:  Chao Wang; Lin-Yi Chen; Qing-Bin Lu; Fuqiang Cui
Journal:  Vaccines (Basel)       Date:  2022-06-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.